Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Depressive Symptoms in Newly Diagnosed Lung Carcinoma: Prevalence and Associated Risk Factors

  • Shahedah, K.K. (Department of Internal Medicine, Kulliyyah of Medicine, International Islamic University Malaysia (IIUM)) ;
  • How, S.H. (Department of Internal Medicine, Kulliyyah of Medicine, International Islamic University Malaysia (IIUM)) ;
  • Jamalludin, A.R. (Department of Community Medicine, Kulliyyah of Medicine, International Islamic University Malaysia (IIUM)) ;
  • Mohd Faiz, M.T. (Department of Psychiatry, Kulliyyah of Medicine, International Islamic University Malaysia (IIUM)) ;
  • Kuan, Y.C. (Department of Internal Medicine, Kulliyyah of Medicine, International Islamic University Malaysia (IIUM)) ;
  • Ong, C.K. (Department of Respiratory Medicine, Penang General Hospital)
  • Received : 2018.05.28
  • Accepted : 2018.10.16
  • Published : 2019.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Depression is a recognized complication of lung cancer underreported in developing countries such as Malaysia. Treating and identifying depression in cancer patients increases survival and quality of life. Our objectives are to study prevalence of depressive symptoms in newly diagnosed lung carcinoma, and examine the relationship of depressive symptoms with other influencing risk factors. Methods: A 2-year, cross sectional study February 2015-February 2017, was conducted at Hospital Tengku Ampuan Afzan, and Penang General Hospital. One hundred and three patients with newly diagnosed, biopsy confirmed primary lung carcinoma were recruited. Self-rated patient's identification sheet, validated Center for Epidemiologic Studies Depression (CES-D), and Dukes University Religion Index score from three different main languages were used. Results: Prevalence of current depressive symptoms (CES-D total score ${\geq}16$) is 37.9%. The result suggests prevalence of those at high risk of moderate to major depression, may need treatment. Multivariate analysis reveals those with good Eastern Cooperation Oncology Group factor (${\eta}2=0.24$, p<0.001) married (${\eta}2=0.14$, p<0.001) with intrinsic religiosity (IR) (${\eta}2=0.07$, p<0.02) are more resistant to depression. Conclusion: One in three of lung carcinoma patients, are at increased risk for depression. Clinicians should be aware that risk is highest in those with poor performance status, single, and with poor IR. We suggest routine screening of depression symptoms as it is feasible, to be performed during a regular clinic visit with immediate referral to psychiatrist when indicated.

Keywords

References

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108. https://doi.org/10.3322/caac.21262
  2. Molina JR, Adjei AA, Jett JR. Advances in chemotherapy of non-small cell lung cancer. Chest 2006;130:1211-9. https://doi.org/10.1378/chest.130.4.1211
  3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65:5-29. https://doi.org/10.3322/caac.21254
  4. Spiegel D. Cancer and depression. Br J Psychiatry Suppl 1996;(30):109-16.
  5. Walker J, Cassidy J, Sharpe M; SMaRT Oncology-3 Trialists. The third symptom management research trial in oncology (SMaRT oncology-3): a randomised trial to determine the efficacy of adding a complex intervention for major depressive disorder (depression care for people with lung cancer) to usual care, compared to usual care alone in patients with lung cancer. Trials 2009;10:92. https://doi.org/10.1186/1745-6215-10-92
  6. Hopwood P, Stephens RJ. Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol 2000;18:893-903. https://doi.org/10.1200/JCO.2000.18.4.893
  7. Vilagut G, Forero CG, Barbaglia G, Alonso J. Screening for depression in the general population with the center for Epidemiologic Studies Depression (CES-D): a systematic review with meta-analysis. PLoS One 2016;11:e0155431. https://doi.org/10.1371/journal.pone.0155431
  8. Montazeri A, Gillis CR, McEwen J. Quality of life in patients with lung cancer: a review of literature from 1970 to 1995. Chest 1998;113:467-81. https://doi.org/10.1378/chest.113.2.467
  9. Pinquart M, Duberstein PR. Depression and cancer mortality: a meta-analysis. Psychol Med 2010;40:1797-810. https://doi.org/10.1017/S0033291709992285
  10. Pirl WF, Greer JA, Traeger L, Jackson V, Lennes IT, Gallagher ER, et al. Depression and survival in metastatic non-smallcell lung cancer: effects of early palliative care. J Clin Oncol 2012;30:1310-5. https://doi.org/10.1200/JCO.2011.38.3166
  11. Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989;2:888-91.
  12. Hann D, Winter K, Jacobsen P. Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res 1999;46:437-43. https://doi.org/10.1016/S0022-3999(99)00004-5
  13. Pirl WF, Temel JS, Billings A, Dahlin C, Jackson V, Prigerson HG, et al. Depression after diagnosis of advanced non-small cell lung cancer and survival: a pilot study. Psychosomatics 2008;49:218-24. https://doi.org/10.1176/appi.psy.49.3.218
  14. Koenig HG. Research on religion, spirituality, and mental health: a review. Can J Psychiatry 2009;54:283-91. https://doi.org/10.1177/070674370905400502
  15. Koenig HG, Hays JC, George LK, Blazer DG, Larson DB, Landerman LR. Modeling the cross-sectional relationships between religion, physical health, social support, and depressive symptoms. Am J Geriatr Psychiatry 1997;5:131-44. https://doi.org/10.1097/00019442-199721520-00006
  16. American Psychiatric Association. Guidelines regarding possible conflict between psychiatrists' religious commitment and psychiatric practice. Am J Psychiatry 1990;147:542. https://doi.org/10.1176/ajp.147.4.542
  17. Ginsburg ML, Quirt C, Ginsburg AD, MacKillop WJ. Psychiatric illness and psychosocial concerns of patients with newly diagnosed lung cancer. CMAJ 1995;152:701-8.
  18. Koenig HG, Bussing A. The Duke University Religion Index (DUREL): a five-item measure for use in epidemological studies. Religions 2010;1:78-85. https://doi.org/10.3390/rel1010078
  19. Nurasikin MS, Aini A, Aida Syarinaz AA, Ng CG. Validity and reliability of the Malay version of Duke University Religion Index (DUREL-M) among a group of nursing student. Malays J Psychiatr 2010;19:MJP-02-12-10.
  20. Wang J, Sun YL, Rong Y, Zhang YH, Wang ZZ. The reliability of Chinese version DUREL scale. J Ningxia Med Univ 2013;35:550-2.
  21. Rodin D, Banihashemi B, Wang L, Lau A, Harris S, Levin W, et al. The Brain Metastases Symptom Checklist as a novel tool for symptom measurement in patients with brain metastases undergoing whole-brain radiotherapy. Curr Oncol 2016;23:e239-47. https://doi.org/10.3747/co.23.2936
  22. Shi Y, Gu F, Hou LL, Hu YQ. Self-reported depression among patients with non-small cell lung cancer. Thorac Cancer 2015;6:334-7. https://doi.org/10.1111/1759-7714.12179
  23. Abhishekh HA, Balaji AL, Mehta RM. Depression in lung cancer patients. Indian J Psychiatry 2014;56:307. https://doi.org/10.4103/0019-5545.140667
  24. Maneeton B, Maneeton N, Reungyos J, Intaprasert S, Leelarphat S, Thongprasert S. Prevalence and relationship between major depressive disorder and lung cancer: a cross-sectional study. Onco Targets Ther 2014;7:815-21.
  25. Chen J, Li W, Cui L, Qian Y, Zhu Y, Gu H, et al. Chemotherapeutic response and prognosis among lung cancer patients with and without depression. J Cancer 2015;6:1121-9. https://doi.org/10.7150/jca.11239
  26. Sullivan DR, Forsberg CW, Ganzini L, Au DH, Gould MK, Provenzale D, et al. Longitudinal changes in depression symptoms and survival among patients with lung cancer: a national cohort assessment. J Clin Oncol 2016;34:3984-91. https://doi.org/10.1200/JCO.2016.66.8459
  27. Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR. Anxiety and depression in patients with lung cancer before and after diagnosis: findings from a population in Glasgow, Scotland. J Epidemiol Community Health 1998;52:203-4. https://doi.org/10.1136/jech.52.3.203
  28. Massie MJ. Prevalence of depression in patients with cancer. In: NIH State-of-the-Science Conference on Symptom Management in Cancer: Pain, Depression, and Fatigue; 2002 Jul 15-17; Bethesda, MD, USA.
  29. Sullivan DR, Forsberg CW, Ganzini L, Au DH, Gould MK, Provenzale D, et al. Depression symptom trends and health domains among lung cancer patients in the CanCORS study. Lung Cancer 2016;100:102-9. https://doi.org/10.1016/j.lungcan.2016.08.008
  30. Vodermaier A, Linden W, Siu C. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst 2009;101:1464-88. https://doi.org/10.1093/jnci/djp336
  31. Krebber AM, Buffart LM, Kleijn G, Riepma IC, de Bree R, Leemans CR, et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology 2014;23:121-30. https://doi.org/10.1002/pon.3409
  32. Mystakidou K, Tsilika E, Parpa E, Katsouda E, Galanos A, Vlahos L. Assessment of anxiety and depression in advanced cancer patients and their relationship with quality of life. Qual Life Res 2005;14:1825-33. https://doi.org/10.1007/s11136-005-4324-3
  33. Kader Maideen SF, Sidik SM, Rampal L, Mukhtar F. Prevalence, associated factors and predictors of depression among adults in the community of Selangor, Malaysia. PLoS One 2014;9:e95395. https://doi.org/10.1371/journal.pone.0095395
  34. Rosenstein DL. Depression and end-of-life care for patients with cancer. Dialogues Clin Neurosci 2011;13:101-8. https://doi.org/10.31887/DCNS.2011.13.1/drosenstein
  35. McCullough ME, Larson DB. Religion and depression: a review of the literature. Twin Res 1999;2:126-36. https://doi.org/10.1375/twin.2.2.126
  36. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: metaanalysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101-7. https://doi.org/10.1001/archinte.160.14.2101

Cited by

  1. Identifying risk factors for depression and anxiety symptoms in patients with chronic lymphocytic leukemia vol.28, pp.4, 2019, https://doi.org/10.1007/s00520-019-04991-y
  2. Effects of Non-pharmacological Intervention on Depression among Patients with Lung Cancer: A Systematic Review and Meta-Analysis vol.21, pp.3, 2021, https://doi.org/10.5388/aon.2021.21.3.140
  3. Functional Disability Among Older Versus Younger Adults With Advanced Non-Small-Cell Lung Cancer vol.17, pp.6, 2021, https://doi.org/10.1200/op.20.01004